Michael Regan, Equity Research Analyst

Weekly Wrapup: Cresco beats on sales and margins, KushCo secures credit, Schottensteins boost investment in Green Growth Brands and more

August 23, 2019 · Updated February 28, 2020

Cresco beats on sales and margin, focuses on brands and distribution The main earnings news for the week was Cresco Labs’ (CSE: CL) second-quarter beat on sales and margin – and its surprise positive EBITDA. Sales of $29.9 million were 8% ahead of the consensus estimate of $27.8 million, as the Illinois-based company noted revenue […]

Read More

Introducing the cannabis comp table

August 20, 2019 · Updated November 18, 2019

Today we introduce the first version of the MJBizDaily Investor Intelligence comp table, one of many new features we’ll be unveiling for Investor Intelligence subscribers.

Read Article

Aurora Cannabis unfazed by revenue miss, Columbia Care anticipates over 50% gross margin potential & more

August 9, 2019 · Updated November 18, 2019

Earnings reports started to ramp this past week. Here are some key takeaways that especially caught our attention at Investor Intelligence this week: Cronos’ EBITDA guidance As detailed in in our Rapid Reaction, Cronos Group shares traded down 4% on Thursday as the Toronto-based company guided larger adjusted EBITDA losses that are larger in the second half […]

Read More

Rapid Reaction: Cronos guides larger EBITDA losses to grow US CBD market

August 8, 2019 · Updated November 18, 2019

Guidance for larger EBITDA losses – and it makes sense Cronos Group on Thursday reported strong Q2 results through the end of June with revenue of CA$10.8 million, well ahead of consensus estimates of CA$7.3 million, and inline gross margin of 53.5%. The Toronto company’s adjusted EBITDA loss of CA$17.8 million was larger than the […]

Read More

Aphria beats revenue expectations by 23%, 4Front announces $200M EBITDA target & more

August 2, 2019 · Updated November 18, 2019

The second-quarter earnings season started off with a bang and a focus on profitability. Here are some of the highlights from this week: Aphria shocks with 13.5% margin, expresses interest in CannTrust The biggest news this week came Thursday when Aphria beat fiscal fourth-quarter revenue expectations by 23% and guided to a 13.5% EBITDA margin […]

Read More

Weekly Wrapup: Beyond the headlines for the week ended July 19, 2019

July 19, 2019 · Updated December 30, 2019

After a slight break, we’ve returned to megadeals in cannabis. The big news this week was Curaleaf’s acquisition of Grassroots Cannabis to create one of the largest cannabis companies in the world, sending the company’s stock up about 20% since the announcement Wednesday. As we noted in our deeper review, the cash and fixed-equity value […]

Read More